JPRN-UMIN000052589
Not yet recruiting
未知
Elucidation of the pathogenesis and new diagnostic or therapeutic methods for biliary tract diseases through bile juice analysis. - Elucidation of the pathogenesis and new diagnostic or therapeutic methods for biliary tract diseases through bile juice analysis.
agoya University Graduate School of Medicine0 sites350 target enrollmentJanuary 1, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Bile duct cancer, primary sclerosing cholangitis, IgG4-related sclerosing cholangitis, secondary sclerosing cholangitis, bile duct stones, cholangitis
- Sponsor
- agoya University Graduate School of Medicine
- Enrollment
- 350
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients considered ineligible for participation in this study by the principal investigator or research assistant. Cases in which ERCP is difficult to perform or ENBD tube placement is difficult Patients who have undergone biliary tract surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The investigation of pathological mechanism and the identification of causal molecule in Anisakiasis -The indentification of species in AnisakiasisAnisakiasisJPRN-UMIN000024348Oita university100
Completed
Not Applicable
Elucidation of pathogenic mechanism and development of diagnostic methods in anaphylaxis by leukocyte analysis and coagulation analysisperioperative anaphylaxisJPRN-UMIN000026557Shinshu University70
Completed
Not Applicable
A clinical approach to reveal mechanism and treatment of steroid induced diabetesDiabetesJPRN-UMIN000037040Kumamoto University Hospital40
Completed
Not Applicable
Pathological diagnosis and clinical characteristics of cerebral amyloid angiopathy-related intracerebral hemorrhageCerebral amyloid angiopathyJPRN-UMIN000014542Aizawa Hospital10
Completed
Not Applicable
Investigation of the pathogenesis and development of new treatments for autoimmune diseases, such as systemic lupus erythematosusRheumatoid arthritisJPRN-UMIN000007012Saitama Medical Center, Saitama Medical Universitity20